NCT03152370View on ClinicalTrials.gov

Preoperative Radiotherapy and E7046 in Rectum Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 17, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

September 30, 2021

Conditions
Neoadjuvant Therapy in Rectal Cancer
Interventions
DRUG

E7046

oral administration

RADIATION

Long Course Chemoradiotherapy (LCRT)

pelvic radiotherapy

RADIATION

Short Course Radiotherapy (SCRT)

pelvic radiotherapy

DRUG

capecitabine

chemotherapy

DRUG

folinic acid/5-FU/oxaliplatin (mFOLFOX-6)

chemotherapy

Trial Locations (5)

10065

Weill Cornell, New York

02114

Massachusetts General Hospital, Boston

Unknown

Marie-Skodowska Curie Cancer Centre, Warsaw

The Christie, Manchester

Mount Vernon Hospital, Northwood

All Listed Sponsors
lead

Adlai Nortye Biopharma Co., Ltd.

INDUSTRY

NCT03152370 - Preoperative Radiotherapy and E7046 in Rectum Cancer | Biotech Hunter | Biotech Hunter